Return to homepagePandemic Pact

COVID-19 Therapeutic Accelerator - ANTICOV - Testing multiple early treatment options for mild COVID-19 infected patients.

  • Funded by Foreign, Commonwealth & Development Office (FCDO)
  • Total publications:0 publications

Grant number: GB-1-204765-114

Grant search

Key facts

  • Disease

    COVID-19

  • Start & end year

    2021
    2023

  • Known Financial Commitments (USD)

    $4,903,860.69

  • Funder

    Foreign, Commonwealth & Development Office (FCDO)

  • Principal Investigator

    N/A

  • Research Location

    Switzerland

  • Lead Research Institution

    Drugs for Neglected Diseases Initiative (DNDi)

  • Research Priority Alignment

    N/A

  • Research Category

    Clinical characterisation and management

  • Research Subcategory

    Supportive care, processes of care and management

  • Special Interest Tags

    N/A

  • Study Type

    Clinical

  • Clinical Trial Details

    Not applicable

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

General: Since the beginning of the COVID-19 pandemic, Drugs for Neglected Diseases initiative (DNDi) and its partners have responded on many fronts, its most notable clinical research effort being the ANTICOV trial, which aims to generate data on new early (outpatient) treatment strategies for mild / moderate (according to different definitions) COVID-19 patients in resource-limited settings to reduce the number progressing to severe forms and to relieve the burden on health systems.; General: Since the beginning of the COVID-19 pandemic, Drugs for Neglected Diseases initiative (DNDi) and its partners have responded on many fronts, its most notable clinical research effort being the ANTICOV trial, which aims to generate data on new early (outpatient) treatment strategies for mild / moderate (according to different definitions) COVID-19 patients in resource-limited settings to reduce the number progressing to severe forms and to relieve the burden on health systems.